Insight Into the Cellular Activities of Tranexamic Acid As an Option for Melasma Treatment

Scientists investigated tranexamic acid’s (TXA) impact on melanocytes, keratinocytes, and inflammatory cells. TXA directly inhibits melanin synthesis in B16 melanoma cells, with an additive effect when combined with α-arbutin.